Brown Advisory’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
VCM
VPM
DAM
Brown Advisory's RMD Position: Q1 2026 in Review
Brown Advisory increased its ResMed (RMD) stake by 4.6% in Q1 2026, buying an estimated $18.2K and bringing the position to 1,667 shares worth $374K. The position accounts for ﹤0.01% of the portfolio, ranked #1148.
Brown Advisory first reported a position in RMD in Q2 2013 and has held it in 21 quarters since. The position peaked at $657K in Q2 2013. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.
- Brown Advisory held 1,667 shares of ResMed worth $374K as of Q1 2026.
- Brown Advisory bought 73 ResMed shares in Q1 2026, an estimated $18.2K.
- ResMed made up ﹤0.01% of Brown Advisory's portfolio in Q1 2026, its #1148 holding.
- Brown Advisory first reported a position in ResMed in Q2 2013 and has held it in 21 quarters since.
- Brown Advisory's ResMed position peaked at $657K in Q2 2013.
- 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.
Based on Brown Advisory's 13F filing for Q1 2026, filed 15 May 2026.